| Product |
Cat# |
IFU |
Incubation |
Stand.Range/Sensitivity |
Specimen |
Type |
Method |
Units |
| HSV 1 IgM CLA |
CLA5199 |
|
30min 37C/ 30/15 min. RT |
|
10 uL serum |
qualitative |
MTPL |
96 wells |
| HSV 2 IgM CLA |
CLA5200 |
|
30min 37C / 30/15min. RT |
|
10 uL serum |
qualitative |
MTPL |
96 Wells |
| HepAK Dot |
DOT4274 |
|
30/30/10-12 min. RT (+30 min d |
no qualitative evaluat. (compare with pos Dot control) // up to |
10 ul serum, plasma |
pos. dot control |
bot strips |
96 (24x4) tests |
| HepAK plus Dot |
DOT4275 |
|
30/30/10-12 min. RT (+30 min. |
no qualit. evaluation (compare w. pos. Dot control) // up to 91 |
10 ul serum, plasma |
pos. dot control |
blot strip |
120 (24x5) tests |
| hPL (Placental Lactogen, Human) |
EIA1283 |
IFU |
40 min. at RT |
1.25-20 mg/ml |
serum |
quantitative |
MTPL |
96 wells |
| HCG (intact), human serum only (human chorionic Gonadotropin) |
EIA1469 |
IFU |
40 min. at RT |
std. range 5 - 1000 mIU/ml |
serum |
quantitative |
MTPL |
96 wells |
| HVA |
EIA1573 |
IFU |
85 min. at RT |
0.125-10 mg/ml |
urine |
quantitative |
MTPL |
96 wells |
| HCG Elisa (serum) |
EIA1783 |
IFU |
1 hr. at RT |
2.0 mIU/ml |
serum |
quantitative |
MTPL |
96 wells |
| HGH (Human Growth Hormone) |
EIA1787 |
IFU |
1 hr at RT |
0.5 ng/ml |
serum |
quantitative |
MTPL |
96 wells |
| H. Pylori IgG (Gastritus & Peptic Ulcer) qualitative |
EIA1791 |
IFU |
1.5 hrs. at RT |
98% |
serum |
qualitative |
MTPL |
96 wells |
| HSV 2 IgM |
EIA1794 |
|
90 min at RT |
|
serum |
qualitative |
MTPL |
96 wells |
| HSV 2 IgG |
EIA1795 |
IFU |
90 min at RT |
|
serum |
qualitative |
MTPL |
96 wells |
| HSV 1 IgG |
EIA1802 |
IFU |
90 min at RT |
|
serum |
qualitative |
MTPL |
96 wells |
| HSV 1 IgM |
EIA1803 |
IFU |
90 min at RT |
|
serum |
qualitative |
MTPL |
96 wells |
| HTLV 1+2 (min order 2 kits) |
EIA1811 |
IFU |
75 min. at 37 C. |
|
serum or plasma |
qualitative |
MTPL |
96 wells |
| HEV IgG (Hepatitis E Virus IgG) (min. order 2 kits) |
EIA1813 |
|
75 min. 37 C. |
cutoff value |
serum or plasma |
qualitative |
MTPL |
96 wells |
| HIAA (5-Hydroxy-3-Indole Acetic Acid) |
EIA1886 |
IFU |
overnight at 2-8 C. |
0.2 mg/L |
urine |
quantitative |
MTPL |
96 wells |
| HCG (total), beta (human serum) |
EIA1911 |
IFU |
60/15 min. |
5-200 mlU/ml |
25 ul serum |
quantitative |
MTPL |
96 wells |
| H. Pylori IgM (qualitative) |
EIA2111 |
IFU |
|
|
|
qualitative |
MTPL |
96 wells |
| HCG (visual) Elisa |
EIA2113 |
IFU |
|
|
|
qualitative |
MTPL |
96 wells |
| Haemophilus influenzae IgG, Elisa |
EIA2530 |
IFU |
60 / 60 / 30 min. |
--- /// 9,1yg.nk |
20ul serum, citrate-, EDTA- or H |
quantitative |
MTPL |
96 wells |
| HSV 1 IgA*, Elisa |
EIA2532 |
IFU |
|
|
|
|
|
96 wells |
| H. Pylori IgG (Gastritus & peptic Ulcer) quantitative |
EIA3057 |
IFU |
|
|
|
quantitative |
MTPL |
96 wells |
| H. Pylori IgA |
EIA3483 |
IFU |
60 min 37 C; 30 / 15 min. RT |
pos. / neg. control |
10 ul serum (1+100 diluted) |
qualitative |
MTPL |
96 wells |
| H. Pylori IgG |
EIA3484 |
IFU |
60 min 37 C; 30 / 15 min. RT |
pos / neg. control |
10 ul serum (1+100 diluted) |
qualitative |
MTPL |
96 wells |
| HSV 1 IgG (Herpes Simplex Virus) |
EIA3485 |
IFU |
60 37 C; 30 / 15 min. RT |
pos. / neg. / cut off control |
10 ul serum (1+100 diluted) |
qualitative |
MTPL |
96 wells |
| HSV 1 IgM (Herpes Simplex Virus) |
EIA3486 |
IFU |
60 37 min. C; 30 / 15 min. RT |
pos. / neg. / cut off control |
10 ul serum (1+100 diluted) |
qualitative |
MTPL |
96 wells |
| HSV 2 IgG (Herpes Simplex Virus) |
EIA3487 |
IFU |
60 min 37 C; 30 / 15 min. RT |
pos./ neg. / cut off control |
10 ul serum (1+100 diluted) |
qualitative |
MTPL |
96 wells |
| HSV 2 IgM (Herpes Simplex Virus) |
EIA3488 |
IFU |
60 min 37 C; 30 / 15 min. RT |
pos. / neg. / cut off control |
10 ul serum (1+100 diluted) |
qualitative |
MTPL |
96 wells |
| HSV 1+2 IgG (Herpes Simplex Virus) |
EIA3489 |
IFU |
60 min. 37 C; 30 / 15 min. RT |
pos. / neg. control |
10 ul serum (1+1)) diluted) |
qualitative |
MTPL |
96 wells |
| HSV 1+2 IgM (Herpes Simplex Virus) |
EIA3490 |
IFU |
60 min. 37 C; 30 / 15 min. RT |
pos./ neg. / cut off control |
10 ul serum (1+100 diluted) |
qualitative |
MTPL |
96 wells |
| Histone, anti- Elisa |
EIA3568 |
IFU |
|
|
|
quantitative |
MTPL |
96 wells |
| Hepatocyte Growth Factor (human) (HGF) |
EIA3791 |
IFU |
3h |
156-10,000 pg/ml < 19 og.nk |
50 ul |
quantitative |
MTPL |
96 wells |
| HAV IgM, anti- (Kit for IgM Antibody to Hepatitis A Virus) (ELISA) |
EIA3889 |
|
|
|
|
qualitative |
MTPL |
96 wells |
| HBeAg (Kit for Hepatitis B e Antigen) (ELISA) |
EIA3890 |
|
|
|
|
qualitative |
MTPL |
96 wells |
| HBe, anti- (Kit for Antibody to Hepatitis B e Antigen) (ELISA) |
EIA3891 |
|
|
|
|
qualitative |
MTPL |
96 wells |
| HBsAg (Kit for Hepatitis B Surface Antigen) (ELISA) |
EIA3892 |
|
|
|
|
qualitative |
MTPL |
96 wells |
| HBs, anti- (Kit for Antibody to Hepatitis B Surface Antigen) (ELISA) |
EIA3893 |
|
|
|
|
qualitative |
MTPL |
96 wells |
| HBc, anti- (Kit for IgG/IgM Antibodies to Hepatitis B Core Antigen) (ELISA) |
EIA3894 |
|
|
|
|
qualitative |
MTPL |
96 wells |
| HBc IgM, anti- Elisa |
EIA3895 |
|
|
|
|
qualitative |
MTPL |
96 wells |
| HCV anti- (Kit for Antibody to Hepatitis C Virus) (ELISA) 3rd generation |
EIA3896 |
|
|
|
|
qualitative |
MTPL |
96 wells |
| HIV 1+2, anti- (Sandwich) (Kit for Ab to human Immunodeficiency Virus 1&2) (ELISA) |
EIA3897 |
|
|
|
|
qualitative |
MTPL |
96 wells |
| H. Pylori IgA (min order 10 kits) |
EIA3902 |
IFU |
60'/60' 37C, 20' RT |
0 - 100 U arb./ml // >98% |
10 ul serum, plasma (human) |
quantitative |
MTPL |
96 wells |
| HCV AB (min order 10 kits) |
EIA3903 |
|
45'/45' 37C, 15' RT / >98% |
neg. / pos. control, qualt. |
10 ul serum, plasma (human) |
qualitative |
MTPL |
192 wells |
| HTLV 1+2 Ab (min 10 kits) ) |
EIA3905 |
IFU |
45'/45' 37C, 15' RT |
pos./neg. control, qualit. / >98 % |
10 ul serum, plasma (human |
qualitative |
MTPL |
96 wells |
| HCV IgM Sandwich (min order 10 kits) |
EIA3908 |
IFU |
60'/60' 37C, 20' RT |
neg. / pos. control, qual. / >98 % |
10 ul serum, plasma (human) |
qualitative |
MTPL |
96 wells |
| HBsAg (confirmatory) (min. 10 kits) |
EIA3949 |
IFU |
2/h/1h/20 min |
controls / 0.1 ug/ml |
200 ul serum, plasma |
qualitative |
MTPL |
96 wells |
| HCV Ab confirmatory (min. order 10 kits) |
EIA3970 |
IFU |
60' 37C / 20' RT |
neg. / pos. controls qualitative |
10 ul Serum, Plasma (human) |
qualitative |
MTPL |
96 wells |
| Histamine Elisa - |
EIA4005 |
IFU |
|
|
serum, plasma, urine, cell cultu |
qualitative |
MTPL |
96 wells |
| H. Pylori IgM (min. order 10 kits) |
EIA4051 |
IFU |
60'/60' 37C, 20' RT |
neg., pos. control / > 98% |
10 ul serum, plasma (human) |
qualitative |
MTPL |
96 wells |